Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02046421
Title Carboplatin, Gemcitabine Hydrochloride, and Mifepristone in Treating Patients With Advanced Breast Cancer or Recurrent or Persistent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors University of Chicago
Indications

ovarian cancer

breast cancer

fallopian tube cancer

peritoneum cancer

Therapies

Mifepristone

Carboplatin + Gemcitabine

Age Groups: adult
Covered Countries USA


No variant requirements are available.